关注
Dr Alex Spratt
Dr Alex Spratt
South Florida Eye Health, Hollywood, Florida, USA
在 sofleyehealth.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Testing an aetiological model of visual hallucinations in Parkinson's disease
DA Gallagher, L Parkkinen, SS O'Sullivan, A Spratt, A Shah, CC Davey, ...
Brain 134 (11), 3299-3309, 2011
1692011
The relationship between diurnal variations in intraocular pressure measurements and central corneal thickness and corneal hysteresis
A Kotecha, DP Crabb, A Spratt, DF Garway-Heath
Investigative ophthalmology & visual science 50 (9), 4229-4236, 2009
952009
Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series
A Kotecha, A Spratt, L Ogunbowale, R dell’Omo, A Kulkarni, C Bunce, ...
Archives of Ophthalmology 129 (2), 145-150, 2011
612011
Optic disc and visual field changes after trabeculectomy
A Kotecha, A Spratt, C Bunce, DF Garway-Heath, PT Khaw, ...
Investigative ophthalmology & visual science 50 (10), 4693-4699, 2009
572009
Visual function and fitness to drive
A Kotecha, A Spratt, A Viswanathan
British medical bulletin 87 (1), 163-174, 2008
562008
Chronic anterior uveitis following bacille Calmette–Guérin vaccination: molecular mimicry in action?
A Spratt, T Key, AJ Vivian
Journal of Pediatric Ophthalmology & Strabismus 45 (4), 252-253, 2008
532008
Quality of life in glaucoma
A Spratt, A Kotecha, A Viswanathan
Journal of Current Glaucoma Practice 2 (1), 39-45, 2008
232008
Predicting visual field loss in ocular hypertensive patients using wavelet-fourier analysis of GDx scanning laser polarimetry
EA Essock, P Gunvant, Y Zheng, DF Garway-Heath, A Kotecha, A Spratt
Optometry and Vision Science 84 (5), E380-E387, 2007
212007
Longitudinal change in central corneal thickness in the Tema Eye Survey
JC Mwanza, SE Tulenko, DL Budenz, E Mathenge, LH Herndon, HY Kim, ...
American Journal of Ophthalmology 186, 10-18, 2018
152018
What's in a name? New glaucoma drugs
A Spratt, L Ogunbowale, R Wormald, W Franks
The Lancet 368 (9538), 826-827, 2006
72006
Anesthesia: 2-Volume Set
RD Miller, LI Eriksson, L Fleisher, JP Wiener-Kronish, WL Young
Elsevier Health Sciences, 2013
52013
Drops and falls
A Spratt, L Ogunbowale, A Khawaja, W Franks
Age and ageing 35 (6), 646-646, 2006
52006
Bevacizumab: a compassionate way of doing business?
A Spratt, L Ogunbowale, W Franks
Eye 21 (6), 890-891, 2007
42007
Treatment of recalcitrant cyclitic neovascular pupillary membranes
A Spratt, LS Blieden, SR Dubovy, A Berrocal, RK Lee
Journal of glaucoma 26 (4), e160-e162, 2017
22017
Clear lens extraction for angle closure
A Spratt, MN Welch, RK Parrish
Ophthalmology 120 (10), e71, 2013
22013
Patient reported outcomes in glaucoma: associations between the NEI VFQ-25 and the GQL-15 and clinical measures of visual function
S Pourjavan, A Spratt, A Kotecha
Investigative Ophthalmology & Visual Science 51 (13), 187-187, 2010
22010
Central retinal vein occlusion heralding the relapse of haematodermic neoplasm
J Tee, A Spratt, K Cwynarski, C Davey
British journal of haematology 143 (3), 305-305, 2008
22008
Incidence of glaucoma progression and rate of visual field deterioration in a cohort of urban Ghanaians
JC Mwanza, SE Tulenko, DL Budenz, LW Herndon, A Hall, G Hay-Smith, ...
Journal of Glaucoma 31 (7), 503-510, 2022
12022
Do subjective and objective indices of disease severity correlate with perceived disability in new glaucoma referrals?
A Bach, L Ogunbowlae, A Kotecha, A Spratt
Austin Journal of Clinical Ophthalmology, 2015
12015
Ophthalmic pathology and visual hallucinations (VH) in PD
D Gallagher, A Spratt, A Shah, F Bremmer, C Davey, A Lees, A Schrag
MOVEMENT DISORDERS 25 (7), S280-S280, 2010
12010
系统目前无法执行此操作,请稍后再试。
文章 1–20